UAB "Nobel Biocare" Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 2,446,261 |
| 212,718 |
| 70,637 |
| 62,993 |
| 5,478 |
| 43.64 |
| 2.58 |
| 796,563 |
| 1,092,963 |
| 38,634 |
| 1,935,078 |
| 2024 |
|---|
| 2,098,995 |
| 185,588 |
| -46,139 |
| -42,779 |
| -3,782 |
| 42.68 |
| -2.04 |
| 795,868 |
| 724,687 |
| 38,251 |
| 1,559,790 |
| 2025 |
|---|
| 2,624,272 |
| 270,265 |
| 244,152 |
| 176,617 |
| 18,189 |
| 49.10 |
| 6.73 |
| 904,494 |
| 939,122 |
| 31,637 |
| 1,916,320 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 2,624,272 |
| 270,265 |
| 244,152 |
| 176,617 |
| 18,189 |
| 49.10 |
| 6.73 |
| 904,494 |
| 939,122 |
| 31,637 |
| 1,916,320 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
2,624,272 €25 % *
Sales per employee (€)
270,265 €46 % *
Profit before tax (€)
244,152 €629 % *
Net Profit (€)
176,617 €513 % *
Profit per employee (€)
18,189 €581 % *
Total profitability (%)
49.10 %15.04 % *
Net profitability (%)
6.73 %429.90 % *
Equity (€)
904,494 €14 % *
Amounts Payable And Liabilities (€)
939,122 €30 % *
Non-current Assets (€)
31,637 €-17 % *
CurrentAssets (€)
1,916,320 €23 % *
